Japanese Encephalitis Prognosis
Japanese encephalitis carries a grave prognosis with a case-fatality ratio of 20-30%, and among survivors, 30-50% will have permanent neurologic or psychiatric sequelae even years after the acute illness. 1
Mortality
The mortality rate for JE is substantial and consistently documented:
- Case-fatality ratio: 20-30% across multiple studies and guideline sources 1, 2
- Recent systematic review data (2000-2018) suggests mortality may be declining to approximately 14% in more recent years, likely due to improved supportive care 3
- Deaths can occur through two patterns:
- Short fulminant course with rapid deterioration
- Prolonged coma leading to eventual death 1
- Common fatal complications include status epilepticus, brain hypoxia, increased intracranial pressure, brainstem herniation, and aspiration pneumonia 1
A recent study from Zhejiang Province (2017-2024) found an 18.87% mortality rate, with 9 out of 10 deaths occurring in adults, highlighting that adult cases have particularly poor outcomes 4.
Long-term Neurological Sequelae
The burden of disability is equally concerning as mortality. Among survivors:
- 30-50% develop permanent neurologic or other sequelae that persist for years 1, 2
- Only 36% of patients recover fully at hospital discharge 3
- One year post-discharge, approximately 49% still have neurological sequelae, while only 46% live normally 3
Specific Sequelae Include:
- Motor deficits: Upper and lower motor neuron weakness, flexion deformities of arms, hyperextension of legs
- Movement disorders: Cerebellar and extrapyramidal signs (though some improve after acute illness)
- Seizures: Recurrent seizure disorders
- Cognitive impairment: Cognitive deficits, learning difficulties
- Psychiatric problems: Behavioral problems, psychiatric issues
- Language impairment 1
Prognostic Factors
Poor Prognostic Indicators:
Clinical factors associated with worse outcomes include:
- Abnormal muscle tone (flaccidity or rigidity) - independent predictor of poor outcome 5
- Elevated CSF protein levels - independent predictor 5
- Lower Glasgow Coma Scale scores - particularly GCS ≤8 5, 6
- Age: Both extremes carry risk, with recent data showing adults (≥18 years) have significantly poorer outcomes 4
- Reflex changes 6
- Unvaccinated status - associated with worse clinical outcomes 4
Important Clinical Context:
The vast majority of JE virus infections are asymptomatic - less than 1% of infected persons develop encephalitis 1. However, once symptomatic encephalitis develops, the prognosis becomes severe.
Age-Specific Considerations
There is an emerging shift in disease epidemiology:
- Traditionally affects children in endemic areas (vast majority <15 years) 1
- In areas with childhood vaccination programs, a greater proportion of cases now occur in adults 1
- Adult cases appear to have worse prognosis - the Zhejiang study showed 90% of deaths occurred in adults despite adults representing only 54.72% of cases 4
Treatment Limitations
No specific antiviral therapy exists to alter disease course. Treatment consists solely of supportive care and complication management 1. Controlled trials have shown no benefit from:
- Corticosteroids
- Interferon alpha-2a
- Ribavirin
- Minocycline
- Intravenous immunoglobulin 1
This lack of disease-modifying therapy underscores the importance of prevention through vaccination and the gravity of the prognosis once symptomatic disease develops.
Rare Complete Recovery
While the overall prognosis is poor, rare cases of complete recovery have been documented even after severe presentations requiring prolonged ICU stays 7. However, these exceptional cases should not alter counseling about the typically grave prognosis, as they represent outliers rather than expected outcomes.